![Joseph Payne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Payne
Vorstandsvorsitzender bei
ARCTURUS THERAPEUTICS HOLDINGS INC.
Vermögen: 12 Mio $ am 31.05.2026
Profil
Joseph E.
Payne was the founder of Arcturus Therapeutics, Inc., founded in 2013, where the title held was Chief Executive Officer from 2013 to 2018.
Mr. Payne is the founder of Arcturus Therapeutics Ltd., founded in 2013, holding the titles of President, Chief Executive Officer & Director since 2018.
Mr. Payne currently serves as President, Chief Executive Officer & Director at Arcturus Therapeutics Holdings, Inc. since 2013.
Former positions include Independent Director at Vallon Pharmaceuticals, Inc. from 2018 to 2023, Principal at Bristol Myers Squibb Co., Staff Scientist at DuPont Pharmaceuticals Co., Senior Manager at Nitto Denko Corp.
from 2009 to 2013, and Research Scientist at Merck Research Laboratories Massachusetts LLC.
Education includes undergraduate studies at Brigham Young University and graduate studies at the University of Calgary.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 16.04.2026 | 1’480’097 ( 5.45% ) | 12 Mio $ | 31.05.2026 |
Aktive Positionen von Joseph Payne
| Unternehmen | Position | Beginn |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Vorstandsvorsitzender | 01.03.2013 |
Arcturus Therapeutics Ltd.
 Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Gründer | 01.03.2013 |
Ehemalige bekannte Positionen von Joseph Payne
| Unternehmen | Position | Ende |
|---|---|---|
| GRI BIOPAR | Direktor/Vorstandsmitglied | 21.04.2023 |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Vorstandsvorsitzender | 01.02.2018 |
| NITTO DENKO CORPORATION | Corporate Officer/Principal | 01.02.2013 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
DuPont Pharmaceuticals Co.
 DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Corporate Officer/Principal | - |
Ausbildung von Joseph Payne
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
11
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Arcturus Therapeutics, Inc.
Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
DuPont Pharmaceuticals Co.
DuPont Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Provides researches and develops pharmaceuticals and imaging products to treat diseases | Health Technology |
Nitto Denko Corp.
 Nitto Denko Corp. Electronic Equipment/InstrumentsElectronic Technology Manufactures and sells information functional materials & printed circuits and adhesive tapes | Electronic Technology |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Calgary
 University of Calgary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Arcturus Therapeutics Ltd.
Arcturus Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops technology and therapeutics for rare diseases | Health Technology |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Wählen Sie MarketScreener 
